139 related articles for article (PubMed ID: 37863800)
21. Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates.
Tozbikian G; George M; Zynger DL
Diagn Pathol; 2019 Jun; 14(1):69. PubMed ID: 31253155
[TBL] [Abstract][Full Text] [Related]
22. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
[TBL] [Abstract][Full Text] [Related]
23. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
[TBL] [Abstract][Full Text] [Related]
24. Flat Epithelial Atypia in Breast Core Needle Biopsies With Radiologic-Pathologic Concordance: Is Excision Necessary?
Grabenstetter A; Brennan S; Salagean ED; Morrow M; Brogi E
Am J Surg Pathol; 2020 Feb; 44(2):182-190. PubMed ID: 31609784
[TBL] [Abstract][Full Text] [Related]
25. Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
Greene AJE; Davis J; Moon J; Dubin I; Cruz A; Gupta M; Moazzez A; Ozao-Choy J; Gupta E; Manchandia T; Kalantari BN; Rahbar G; Dauphine C
Ann Surg Oncol; 2024 May; 31(5):3177-3185. PubMed ID: 38386195
[TBL] [Abstract][Full Text] [Related]
26. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
Wagoner MJ; Laronga C; Acs G
Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
[TBL] [Abstract][Full Text] [Related]
27. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
28. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
29. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy.
Prowler VL; Joh JE; Acs G; Kiluk JV; Laronga C; Khakpour N; Lee MC
Breast; 2014 Aug; 23(4):352-6. PubMed ID: 24518220
[TBL] [Abstract][Full Text] [Related]
30. Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.
Lewin AA; Mercado CL
AJR Am J Roentgenol; 2020 Feb; 214(2):265-275. PubMed ID: 31825261
[No Abstract] [Full Text] [Related]
31. The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
Willers N; Neven P; Floris G; Colpaert C; Oldenburger E; Han S; Van Ongeval C; Smeets A; Duhoux FP; Wildiers H; Denolf P; Laudus N; Dequeker E; De Brabander I; Van Damme N; De Schutter H
Clin Breast Cancer; 2023 Jun; 23(4):e273-e280. PubMed ID: 37085379
[TBL] [Abstract][Full Text] [Related]
32. High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision.
Harbhajanka A; Gilmore HL; Calhoun BC
Mod Pathol; 2022 Nov; 35(11):1500-1508. PubMed ID: 35654997
[TBL] [Abstract][Full Text] [Related]
33. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
[TBL] [Abstract][Full Text] [Related]
34. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy.
Rizzo M; Lund MJ; Oprea G; Schniederjan M; Wood WC; Mosunjac M
Ann Surg Oncol; 2008 Apr; 15(4):1040-7. PubMed ID: 18204989
[TBL] [Abstract][Full Text] [Related]
35. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
[TBL] [Abstract][Full Text] [Related]
36. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model.
Linsk A; Mehta TS; Dialani V; Brook A; Chadashvili T; Houlihan MJ; Sharma R
Breast J; 2018 Mar; 24(2):115-119. PubMed ID: 28833923
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
Co M; Kwong A; Shek T
Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
[TBL] [Abstract][Full Text] [Related]
39. Flat epithelial atypia on core needle biopsy, must we surgically excise?
Acott AA; Mancino AT
Am J Surg; 2016 Dec; 212(6):1211-1213. PubMed ID: 27832842
[TBL] [Abstract][Full Text] [Related]
40. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
Kunju LP; Kleer CG
Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
